Status:

COMPLETED

Longitudinal Study of Oscillatory Positive Expiratory Pressure (oPEP) in Stable COPD

Lead Sponsor:

Western University, Canada

Collaborating Sponsors:

London Health Sciences Centre

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

50-85 years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of four times daily oscillatory Positive Expiratory Pressure (oPEP) (Aerobika ®) use over 4 weeks in individuals with stable chronic ob...

Detailed Description

Cough and sputum production is common in chronic obstructive pulmonary disease (COPD), both of which are associated with significant morbidity and other adverse clinical outcomes. Airway clearance tec...

Eligibility Criteria

Inclusion

  • Subjects male and female aged 40-85 with a clinical diagnosis of chronic obstructive pulmonary disease (COPD)
  • Subject understands the study procedures and is willing to participate in the study as indicated by signature on the informed consent
  • Subject is judged to be in otherwise stable health on the basis of medical history
  • Subject is ambulatory and can perform the 6MWT
  • Subject able to perform reproducible pulmonary function testing (i.e., the 3 best acceptable spirograms have FEV1 values that do not vary more than 5% of the largest value or more than 100 ml, whichever is greater).
  • FEV1 \>25% predicted
  • FVC \> 25% predicted and \>0.5L

Exclusion

  • Patient is, in the opinion of the investigator, mentally or legally incapacitated, preventing informed consent from being obtained, or cannot read or understand the written material. Capacity to consent will be determined by either Dr. McCormack at the time of the clinic visit or Sandra Blamires, the study coordinator.
  • Patient is unable to perform spirometry or plethysmography maneuvers
  • Patient is pregnant

Key Trial Info

Start Date :

July 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2013

Estimated Enrollment :

17 Patients enrolled

Trial Details

Trial ID

NCT02282189

Start Date

July 1 2012

End Date

January 1 2013

Last Update

June 27 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Robarts Research Insitute; The University of Western Ontario; London Health Sciences Centre

London, Ontario, Canada, N6A 5B7